Factual and Procedural Background
This claim concerns CF Partners (UK) LLP ("CFP") seeking compensation for breach of an exclusivity agreement and misuse of confidential information related to the pursuit and acquisition by Barclays Bank PLC ("Barclays") of Bryggpipan AB (formerly Tricorona AB) ("Tricorona"). CFP contends Barclays exploited confidential information provided by CFP, who was seeking lending and M&A advice to acquire Tricorona, to acquire Tricorona itself for its own profit.
Tricorona operated in the carbon credits market with a large portfolio ("the Tricorona Portfolio") of Certified Emission Reductions ("CERs"), rights to emit carbon. CFP identified a business opportunity in acquiring and monetising this portfolio, requiring external finance and equity partners.
In 2008, CFP approached Barclays through IVC International Limited ("IVC"), which had a relationship with Barclays, to seek financial assistance and advice. CFP code-named the opportunity "Project Arctic Fox" and Barclays "Project Carbonara". CFP alleges the opportunity was provided to Barclays subject to confidentiality and exclusivity obligations, which Barclays breached by developing a "strategic partnership" with Tricorona culminating in Barclays acquiring Tricorona ("Project Pomodoro").
Project Pomodoro completed in July 2012, after which Barclays sold Tricorona under "Project Rose" for a substantial profit. CFP claims Barclays' acquisition was based on confidential information revealing the portfolio's embedded value, which Barclays misused in breach of confidence and exclusivity obligations.
Barclays had a prior relationship with Tricorona ("Project Conifer") in 2007 but abandoned acquisition plans due to concerns about management and portfolio quality. CFP contends that information it provided changed Barclays' perception, leading to the later acquisition.
The litigation was complex and extensive, involving numerous witnesses, tens of thousands of documents, and detailed expert evidence on the carbon market and legal principles. CFP claims against both Barclays and Tricorona include breach of confidence, breach of exclusivity, and inducement to breach confidentiality.
Legal Issues Presented
- What were the nature and scope of duties owed between the parties in contract and equity?
- Did CFP provide confidential information to Barclays and/or Tricorona the misuse of which is actionable?
- What was the scope and duration of any duty of confidence?
- Did the Defendants misuse CFP's confidential information in Project Pomodoro?
- Did Barclays induce Tricorona to breach its contractual duty of confidence to CFP?
- Are Barclays and Tricorona jointly liable for each other's equitable breaches of confidence?
- Did Barclays agree with CFP not to acquire Tricorona or conflict itself in acting on CFP's proposed acquisition?
- Did Tricorona induce Barclays to breach its contractual agreement with CFP?
- If misuse by Defendants is established, what remedies are appropriate for CFP?
- Is CFP liable to Tricorona on its counterclaim, and what remedies are appropriate?
- Do the facts giving rise to Tricorona's counterclaim provide any defence to CFP's claims against them?
Arguments of the Parties
Appellant's Arguments (CFP)
- CFP contends Barclays breached duties of confidence and exclusivity by misusing confidential information to acquire Tricorona for its own benefit.
- CFP claims the confidential information included a composite "Big Idea" revealing Tricorona's undervalued portfolio and a route to monetise it, particularly Large Hydro CERs.
- CFP asserts Barclays failed to disclose a conflict of interest arising from prior dealings with Tricorona.
- CFP alleges Tricorona also breached confidentiality and induced Barclays to breach its obligations.
- CFP seeks compensation by account of profits or damages, arguing the misuse caused substantial loss and unfair advantage.
- CFP claims the exclusivity release agreement was not intended to release Barclays from exclusivity obligations and should be rectified or rescinded alternatively estopped.
Defendants' Arguments (Barclays and Tricorona)
- Barclays denies breach of confidentiality or exclusivity, contending information lacked necessary quality of confidence or had expired.
- Barclays asserts it did not misuse information materially or in a way damaging to CFP; any change in perception was due to market developments and internal expertise.
- Barclays contends any exclusivity obligations ended by the exclusivity release agreement, which allowed it to pursue Tricorona for its own account.
- Tricorona denies breach of confidentiality and joint liability claims, asserting no duty was owed or breached.
- Defendants rely on CFP's misuse of Tricorona's confidential information as a defence ("unclean hands").
- Barclays argues the acquisition was driven by strategic considerations unrelated to CFP's confidential information and that the "Big Idea" was publicly available or of limited value.
Table of Precedents Cited
| Precedent |
Rule or Principle Cited For |
Application by the Court |
| Campbell v MGN Ltd [2004] UKHL 22 |
Establishment of duty of confidence when information is fairly and reasonably regarded as confidential. |
Confirmed the existence of duty of confidence owed by Barclays to CFP in respect of confidential information. |
| Coco v A.N. Clark (Engineers) Ltd [1969] RPC 41 |
Information must have the necessary quality of confidence. |
Applied to assess confidentiality of information provided by CFP. |
| Bristol and West Building Society v Mothew [1998] Ch 1 |
Distinction between fiduciary duty and duty of confidence. |
Clarified that fiduciary duties were not alleged; duty of confidence was the focus. |
| Vercoe and Pratt v Rutland Fund Management Ltd [2010] EWHC 424 |
Contractual terms generally define scope of confidentiality obligations. |
Considered in relation to exclusivity and confidentiality agreements between parties. |
| Chartbrook Ltd v Persimmon Homes Ltd [2009] 1 AC 1101 |
Requirements for rectification of contracts on common mistake. |
Referenced in claims for rectification of exclusivity release. |
| Central London Property Trust Ltd v High Trees House Ltd [1947] KB 130 |
Doctrine of promissory estoppel. |
Considered in relation to alleged estoppel preventing Barclays from relying on exclusivity release. |
| Inntrepreneur Pub Co v East Crown Ltd [2000] 2 Ll Rep 611 |
Pre-contractual statements only have contractual effect if intended. |
Applied to assess parties' intention in exclusivity discussions. |
| Arklow Investments Ltd v Maclean [2000] 1 WLR 594 |
Misuse requires actual use of confidential information, not mere influence. |
Applied to distinguish misuse from mere galvanisation by confidential information. |
| Attorney-General v Observer Ltd (Spycatcher) [1990] 1 AC 109 |
Confidant must have notice or agreement that information is confidential. |
Supported the establishment of duty of confidence. |
| Walsh v Shanahan [2013] EWCA Civ 411 |
Discretionary nature of account of profits remedy in breach of confidence claims. |
Guided the court’s decision to decline account of profits in favour of damages. |
| Wrotham Park Estate Co Ltd v Parkside Homes Ltd [1974] 1 WLR 798 |
Assessment of damages by hypothetical negotiation for release of restrictive covenants. |
Applied as the basis for assessing damages for breach of confidence. |
| Experience Hendrix LLC v PPX Enterprises Inc [2003] EWCA Civ 323 |
Further elaboration of Wrotham Park damages and account of profits discretion. |
Supported the court’s approach to remedies. |
| Pell Frischmann Engineering Ltd v Bow Valley Iran Ltd [2009] UKPC 45 |
Consideration of post-breach events in assessing Wrotham Park damages. |
Considered in relation to timing and scope of damages. |
| Fiona Trust & Holding Corp v Privalov [2008] EWHC 1748 |
Clean hands doctrine in equity. |
Considered and rejected as a defence to CFP’s claims. |
| Hubbard v Vosper [1972] 2 QB 84 |
Clean hands defence applied to breach of confidence claims. |
Referenced in relation to unclean hands defence. |
Court's Reasoning and Analysis
The court carefully examined the factual and legal matrix surrounding CFP's claims against Barclays and Tricorona for breach of confidentiality and exclusivity obligations. It found that CFP provided confidential information of substantial value and quality ("the Big Idea") to Barclays and Tricorona in the context of Project Arctic Fox/Carbonara, which was instrumental in altering Barclays' perception of Tricorona's portfolio, particularly the value and marketability of Large Hydro CERs.
The court distinguished between a duty of confidence and an obligation of exclusivity, finding no enforceable exclusivity agreement between CFP and Barclays after the exclusivity release agreement of March 2009, which effectively discharged any such obligations. Consequently, CFP's claims for breach of exclusivity fail.
Barclays was found to have breached its equitable duty of confidence to CFP by misusing confidential information not solely for the purpose for which it was provided, notably by developing a strategic partnership with Tricorona from early 2009 onward and ultimately acquiring Tricorona (Project Pomodoro). This misuse included the use of confidential spreadsheets, expressions of interest, and other material, despite internal policies and contractual obligations.
The court found that Ms Patel, a key Barclays figure, operated on both sides of the Chinese Wall, facilitating misuse of confidential information. Tricorona was also found to have breached its contractual and equitable duties of confidence to CFP by using confidential information to its advantage, including in dealings with Barclays, but the resulting loss attributable to Tricorona was comparatively minor.
Claims of inducement of breach of exclusivity by Tricorona and of breach of confidence inducement by Barclays were considered but found either superfluous or unsupported given the court's findings on exclusivity and confidentiality breaches.
The court rejected the defendants' "unclean hands" defence, finding CFP's misconduct insufficiently grave or connected to bar equitable relief.
Regarding remedies, the court declined to award an account of profits, finding damages to be the appropriate remedy in the commercial context without fiduciary duties. It adopted the Wrotham Park/negotiations damages approach to assess compensation, focusing on a hypothetical negotiation in January 2009 when misuse began.
The court assessed the value of the confidential information and its release price by reference to brokerage fees on a proportion of the CER portfolio, particularly Large Hydro CERs, concluding a reasonable negotiated sum of approximately €10 million. It considered but rejected claims for equity participation or larger sums based on hindsight or unrealistic assumptions.
The court acknowledged the complexity and breadth of the case, the difficulty in precise quantification, and the necessity of a broad judgment. It also noted the importance of subsequent market developments and other factors influencing Barclays' acquisition of Tricorona, but maintained that CFP's confidential information was a material and influential factor in the initial change of perception and strategic relationship development.
Holding and Implications
DISMISSED the claims against Barclays for breach of exclusivity obligations, on the basis that no enforceable exclusivity agreement subsisted after the exclusivity release agreement.
UPHELD CFP's claims for breach of equitable duties of confidence by Barclays and Tricorona, finding misuse of confidential information by both defendants in the context of Project Arctic Fox and its aftermath.
REJECTED the defendants' unclean hands defence.
ORDERED damages to CFP assessed on a Wrotham Park/negotiations damages basis, with compensation fixed at approximately €10 million for the misuse of confidential information.
NO NEW PRECEDENT is established; the decision applies established principles of confidentiality, exclusivity, equitable duties, and remedies. The ruling clarifies application of these principles in complex commercial transactions involving carbon credit portfolios and financial institutions.
The decision results in CFP receiving compensation for misuse of its confidential information but does not grant exclusivity or prevent Barclays from acquiring Tricorona. The court's findings emphasize the importance of clear contractual terms, effective internal controls (such as Chinese Walls), and full disclosure of conflicts in such transactions.